D61.810 — Antineoplastic chemotherapy induced pancytopenia
D61.810 is a billable, specific ICD-10-CM code for antineoplastic chemotherapy induced pancytopenia. It is valid for submission on a claim.
Excludes2 — not included here, but may coexist
The excluded condition is not part of this code, but a patient can have both. You may code both.
- aplastic anemia due to antineoplastic chemotherapy (D61.1)
Risk adjustment
D61.810 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
D61.810 is named in 18 Medicare coverage policies — 18 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A55717Billing and Coding: Lab: Flow Cytometry
- A56421Billing and Coding: CT of the Abdomen and Pelvis
- A56464Billing and Coding: Flow Cytometry
- A56718Billing and Coding: Intravenous Immunoglobulin (IVIG)
How D61.810 is indexed
Coders do not find codes by browsing the tabular list — they look them up in the alphabetic index, under the word the physician wrote. These are the index entries that lead here, so you can see which chart wordings map to D61.810.
- Pancytopenia›antineoplastic chemotherapy induced
Related codes at this level
Codes that share D61.81. If D61.810 is not quite right, the correct code is usually one of these.
Questions about D61.810
- Is D61.810 a billable ICD-10-CM code?
- Yes. D61.810 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does D61.810 sit in the tabular list?
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89), in the block Aplastic and other anemias and other bone marrow failure syndromes (D60-D64).